Benchmarking reverse docking through AlphaFold2 human proteome
Protein Science · 2024
DOI: 10.1002/pro.5167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, 2024. Verfasst von Qing Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China. Hauptthemen laut MEDLINE: Proteome, Molecular Docking Simulation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Macao Polytechnic University, Ministry of Education Singapore, National Key R&D Program of China.
Abstract (Originalsprache)
Predicting the binding of ligands to the human proteome via reverse‐docking methods enables the understanding of ligand's interactions with potential protein targets in the human body, thereby facilitating drug repositioning and the evaluation of potential off‐target effects or toxic side effects of drugs. In this study, we constructed 11 reverse docking pipelines by integrating site prediction tools (PointSite and SiteMap), docking programs (Glide and AutoDock Vina), and scoring functions (Glide, Autodock Vina, RTMScore, DeepRMSD, and OnionNet‐SFCT), and then thoroughly benchmarked their predictive capabilities. The results show that the Glide_SFCT (PS) pipeline exhibited the best target prediction performance based on the atomic structure models in AlphaFold2 human proteome. It achieved a success rate of 27.8% when considering the top 100 ranked prediction. This pipeline effectively narrows the range of potential targets within the human proteome, laying a foundation for drug target prediction, off‐target assessment, and toxicity prediction, ultimately boosting drug development. By facilitating these critical aspects of drug discovery and development, our work has the potential to ultimately accelerate the identification of new therapeutic agents and improve drug safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
- Shanghai Zelixir Biotech Company Ltd., China.
- School of Biological Sciences, Nanyang Technological University, Singapore.
- Shenzhen Zelixir Biotech Company Ltd., China.
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
ORCID-Profile: Jingjing Guo
Förderung
- Macao Polytechnic University
- Ministry of Education Singapore
- National Key R&D Program of China
- National Key Research and Development Program of China
Zitieren
APA
Luo, Q., Wang, S., Li, H. Y., Zheng, L., Mu, Y., & Guo, J. (2024). Benchmarking reverse docking through AlphaFold2 human proteome. Protein Science. https://doi.org/10.1002/pro.5167
Vancouver
Luo Q, Wang S, Li HY, Zheng L, Mu Y, Guo J. Benchmarking reverse docking through AlphaFold2 human proteome. Protein Science. 2024. doi:10.1002/pro.5167
BibTeX
@article{Luo2024,
author = {Luo, Qing and Wang, Sheng and Li, Hoi Yeung and Zheng, Liangzhen and Mu, Yuguang and Guo, Jingjing},
title = {Benchmarking reverse docking through AlphaFold2 human proteome},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.5167}
}
EUVIMED